Report #2841909

Received May 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: IN
Recovered: Unknown
Vaccinated: Apr 15, 2025
Onset: Apr 15, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	G79C4	—

Symptoms (1)

Underdose

Symptom narrative

pediatric dose of the Havrix vaccine was given to an adult; pediatric dose of the Havrix vaccine was given to an adult; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 42-year-old female patient who received HAV (Havrix pediatric) (batch number G79C4, expiry date 20-SEP-2025) for prophylaxis. On 15-APR-2025, the patient received Havrix pediatric. On 15-APR-2025, an unknown time after receiving Havrix pediatric, the patient experienced adult use of a child product (Verbatim: pediatric dose of the Havrix vaccine was given to an adult) and underdose (Verbatim: pediatric dose of the Havrix vaccine was given to an adult). The outcome of the adult use of a child product and underdose were not applicable. Additional Information: GSK Receipt Date: 15-MAY-2025 Nurse reported that a pediatric dose of the Havrix vaccine was given to an adult patient, which led to adult use of child product and underdose.